Antibacterial efficacy of accelerated photoactivated chromophore for keratitis-corneal collagen cross-linking (PACK-CXL).
Details
Serval ID
serval:BIB_5BF2B30BA439
Type
Article: article from journal or magazin.
Collection
Publications
Institution
Title
Antibacterial efficacy of accelerated photoactivated chromophore for keratitis-corneal collagen cross-linking (PACK-CXL).
Journal
Journal of refractive surgery
ISSN
1081-597X (Print)
ISSN-L
1081-597X
Publication state
Published
Issued date
12/2014
Peer-reviewed
Oui
Volume
30
Number
12
Pages
850-854
Language
english
Notes
Publication types: Journal Article ; Research Support, Non-U.S. Gov't
Publication Status: ppublish
Publication Status: ppublish
Abstract
To investigate whether optimized photoactivated chromophore for keratitis-corneal collagen cross-linking (PACK-CXL) treatment settings allow accelerating treatment while maintaining antibacterial efficacy.
Staphylococcus aureus and Pseudomonas aeruginosa strains were irradiated with ultraviolet-A light of equal fluence but different intensity settings (18 mW/cm² for 5 minutes and 36 mW/cm² for 2.5 minutes). The killing rate was determined by comparing the number of colony-forming units between cross-linked specimens and non-irradiated controls. The potential additional effect of 0.001% benzalkonium chloride was also investigated.
The killing rates for Staphylococcus aureus were 92.5% ± 5.5% (5 minutes at 18 mW/cm²) and 94.4% ± 2.9% (2.5 minutes at 36 mW/cm²). For Pseudomonas aeruginosa, the killing rates were 93.2% ± 8.3% (5 minutes at 18 mW/cm²) and 92.9% ± 5.0% (2.5 minutes at 36 mW/cm²). The presence of benzalkonium chloride in the riboflavin solution did not increase the killing rate significantly.
The antibacterial efficacy of PACK-CXL follows the Bunsen-Roscoe law of reciprocity and can be maintained even when the irradiation intensity is considerably increased. These optimized settings may allow a shortened treatment time in the future for PACK-CXL and thus help facilitate the transition from the operating room to the slit lamp for treatment.
Staphylococcus aureus and Pseudomonas aeruginosa strains were irradiated with ultraviolet-A light of equal fluence but different intensity settings (18 mW/cm² for 5 minutes and 36 mW/cm² for 2.5 minutes). The killing rate was determined by comparing the number of colony-forming units between cross-linked specimens and non-irradiated controls. The potential additional effect of 0.001% benzalkonium chloride was also investigated.
The killing rates for Staphylococcus aureus were 92.5% ± 5.5% (5 minutes at 18 mW/cm²) and 94.4% ± 2.9% (2.5 minutes at 36 mW/cm²). For Pseudomonas aeruginosa, the killing rates were 93.2% ± 8.3% (5 minutes at 18 mW/cm²) and 92.9% ± 5.0% (2.5 minutes at 36 mW/cm²). The presence of benzalkonium chloride in the riboflavin solution did not increase the killing rate significantly.
The antibacterial efficacy of PACK-CXL follows the Bunsen-Roscoe law of reciprocity and can be maintained even when the irradiation intensity is considerably increased. These optimized settings may allow a shortened treatment time in the future for PACK-CXL and thus help facilitate the transition from the operating room to the slit lamp for treatment.
Keywords
Animals, Anti-Bacterial Agents/pharmacology, Anti-Bacterial Agents/therapeutic use, Benzalkonium Compounds/pharmacology, Colony Count, Microbial, Corneal Ulcer/drug therapy, Corneal Ulcer/microbiology, Eye Infections, Bacterial/drug therapy, Eye Infections, Bacterial/microbiology, Photosensitizing Agents/therapeutic use, Pseudomonas Infections/drug therapy, Pseudomonas Infections/microbiology, Pseudomonas aeruginosa/drug effects, Pseudomonas aeruginosa/isolation & purification, Pseudomonas aeruginosa/radiation effects, Riboflavin/pharmacology, Riboflavin/therapeutic use, Staphylococcal Infections/drug therapy, Staphylococcal Infections/microbiology, Staphylococcus aureus/drug effects, Staphylococcus aureus/isolation & purification, Staphylococcus aureus/radiation effects, Swine, Ultraviolet Rays
Pubmed
Web of science
Create date
08/03/2022 10:33
Last modification date
26/03/2022 6:35